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In addition, many patients ovulate but do not achieve pregnancy pregnancy rate could be improved by human chorionic even after their anovulation has been corrected. For these gonadotrophin (HCG) priming 36 h before immature oocyte women, in-vitro fertilization (IVF) is the standard treatment, retrieval in patients with polycystic ovarian syndrome but there is a significantly higher risk of OHSS compared (PCOS). Immature oocyte retrieval was performed on day with treatment in women with normal ovaries (MacDougall 10-14 of the cycles and patients were randomly allocated et al., 1993) . either to be primed with 10 000 IU of HCG before the Recovery of immature oocytes followed by in-vitro maturaretrieval, or not primed. Immature oocytes were cultured tion (IVM) of these immature oocytes is a potentially useful for 24-48 h in TC-199 medium with 20% (v/v) inactivated treatment for women with PCOS-related infertility since the fetal bovine serum (FBS) supplemented with 75 mIU/ml immature oocytes from these women retain their maturational follicle stimulating hormone (FSH) and luteinizing hormone and developmental competence (Trounson et al., 1994) .
In (LH). Intracytoplasmic sperm injection (ICSI) was per-
comparison with conventional IVF, the major benefits of IVM formed in all mature oocytes and the resulting embryos treatment include avoidance of the risk of OHSS, reduced were transferred on day 2 or 3 after ICSI. A total of 17 cost, and less complicated treatment. However, the maturation patients underwent 24 completed treatment cycles. Thirteen rate of immature oocytes retrieved from women with PCOS cycles were primed with HCG and 11 other cycles were is lower than that of those retrieved from women with normal not primed. The mean number of oocytes retrieved was menstrual cycles (Cha and Chian, 1998) . There is a paucity comparable in the two groups (7.8 ⍨ 3.9 versus 7.4 ⍨ of information about the maturational capacity of immature 5.2). The percentage of oocytes achieving maturation at 48 oocytes derived from women with PCOS. h was significantly higher (P < 0.05) in the HCG-primed Several authors have reported pregnancies following the group (84.3%, 86/102) than in the non-HCG-primed group transfer of embryos produced from immature oocytes derived (69.1%, 56/81). Oocyte maturation was hastened in the from stimulated ovaries (Veeck et al., 1983; Prins et al., 1987 ; HCG-primed group. Following 24 h of culture, 78. 2 ⍨ Nagy et al., 1996; Edirisinghe et al., 1997; Jaroudi et al., 7 .1% of oocytes were matured in the HCG-primed group 1997; Liu et al., 1997; Tucker et al., 1998) . However, the compared with 4.9 ⍨ 2.5% of oocytes in the non-HCGpregnancy rate reported is correspondingly low. It has been primed group (P < 0.001). There were no significant demonstrated that morphological and molecular differences differences in the rates of oocyte fertilization and cleavage exist between immature oocytes retrieved from stimulated and in these two groups. There were five clinical pregnancies unstimulated ovaries (Chian et al., 1997) . Although the time (38.5%) in the HCG-primed group, and three pregnancies courses of germinal vesicle breakdown (GVBD) and oocyte (27.3%) in the non-HCG-primed group.
maturation are different between immature oocytes retrieved Key words: HCG/human/immature oocyte/in-vitro maturation/ from stimulated and unstimulated ovaries, the final rates of polycystic ovarian syndrome oocyte maturation are not different in these two groups (Cha and Chian, 1998 ). It appears that the oocytes retrieved from small follicles in women undergoing ovarian stimulation respond to human chorionic gonadotrophin (HCG) which Introduction promotes the initiation of oocyte maturation. However, it remains unclear whether priming with HCG before immature Polycystic ovarian syndrome (PCOS) is one of the most common reproductive disorders in women of childbearing oocyte retrieval in unstimulated ovaries could improve the rates and time course of oocyte maturation and fertilization, age. It has a heterogeneous presentation, which is clinically characterized by anovulation and hyperandrogenism, and on as well as the embryo quality. The present study was designed to determine whether pelvic ultrasound examination shows numerous antral follicles within the ovaries (Adams et al., 1986) . Women with PCOS priming with HCG 36 h before immature oocyte retrieval alters the rates of oocyte maturation, fertilization and early embryo development in patients with PCOS.
Materials and methods
A total of 17 patients with PCOS underwent 24 completed treatment cycles. All patients were under 41 years of age (mean 35.4 Ϯ 4.9 years) and presented with irregular menstrual cycles, anovulation (determined by ultrasound; see below) and a minimum 2-year history of infertility. All patients had an ultrasound appearance of polycystic ovaries and elevated serum testosterone concentrations. An ultrasound diagnosis of PCOS was made when there were more than 10 small cysts/follicles (2-8 mm diameter) around a dense core of stroma. The serum testosterone concentration was Ͼ1.2 nmol/l on day 2 or 3 of the baseline ultrasound scan. Body mass index (BMI) was not calculated for these patients. The serum luteinizing hormone (LH) concentration was Ͼ10 IU/ml on day 2 of bleeding for all patients. All patients had failed to conceive after at least six cycles of ovulation induction with clomiphene citrate or gonadotrophins and intrauterine insemination. The study was approved by the Research Ethics Board of the Hospital. The treatment cycle was initiated by the administration of intravaginal progesterone (Prometrium; Schering, Pointe-Claire, Quebec, Canada) in a dose of 300 mg daily for 10 days. The timing of the start of treatment was random, as all patients had irregular menstrual cycles. Withdrawal bleeding occurred within 3 days after the last dose. On day 2 or 3 following the onset of menstrual bleeding, the patients underwent a baseline ultrasound scan to ensure that no ovarian cysts were present. Transvaginal ultrasound scans were repeated on day 8 to exclude the development of a dominant follicle. The size of all follicles on ultrasound scan had to be Ͻ10 mm diameter on day 8 of the cycle.
Oocyte retrieval was performed on day 10 to 14 of the cycle. Figure 1 . Immature human oocytes retrieved from (a) human Using a computerized random table, the patients were assigned either chorionic gonadotrophin (HCG)-primed and (b) non-HCG-primed to be primed with 10 000 IU HCG (Profasi; Serono, Oakville, Ontario, groups. Note that germinal vesicle breakdown has occurred in (a), Canada) (group A), or not primed (group B). In group A the HCG while in (b) the intact germinal vesicle is clearly observed.
(Original magnification ϫ400). was given s.c. to patients 36 h before oocyte retrieval. Transvaginal ultrasound-guided oocyte collection was performed using a specially designed 17G single-lumen aspiration needle (K-OPS-1235-Wood, containing 1 ml of maturation medium, TC-199 medium supplemented with 20% FBS, 25 mol/l pyruvic acid (Sigma Chemical Co.), Cook, Australia) with an aspiration pressure of 7.5 kPa. Aspiration of all small follicles was performed under spinal anaesthesia. Oocytes 75 mIU/ml follicle stimulating hormone (FSH) ϩ LH (Humegon; Organon, Scarborough, Ontario, Canada) at 37°C in an atmosphere were collected in 10 ml culture tubes (Falcon, Franklin Lakes, NJ, USA) containing 2 ml warm 0.9% saline with 2 IU/ml heparin of 5% CO 2 and 95% air with high humidity. Following culture, the maturity of the oocytes was determined under the microscope at 12 h (Baxter, Toronto, Ontario, Canada).
Following oocyte collection, the oocytes were evaluated for the intervals for up to 48 h. The oocytes which were mature at the time of checking were presence or absence of a germinal vesicle (GV) in the cytoplasm of the oocyte (Figure 1) , and the immature oocytes were then transferred denuded of cumulus cells using finely drawn glass pipettes following 1 min exposure to 0.1% hyaluronidase solution (Medi-Cult, Hopkininto maturation medium for culture. To identify whether GV was present in the oocyte cytoplasm, the special technique of observation ton, MA, USA) ready for intracytoplasmic sperm injection (ICSI). Spermatozoa for ICSI were prepared by mini-Percoll separation (45% called 'sliding' was employed under the stereomicroscope. Briefly, the cumulus-oocyte complex (COC) was allowed to slide slowly and 90% gradients) at 560 g for 20 min. Following Percoll separation, the sperm pellet was washed twice (200 g) with 2 ml of Medi-Cult down from one side to the other on the bottom of the tissue culture dish (60ϫ15 mm; Falcon), the COC being observed under the IVF medium. A single spermatozoon was injected into each metaphase II oocyte. Following ICSI, each oocyte was transferred into 20 µl microscope. During COC sliding, it was possible to observe clearly whether or not the oocyte cytoplasm contained a GV. If no GV was droplet of Medi-Cult IVF medium in a tissue culture dish (35ϫ10 mm; Falcon) under mineral oil. Fertilization was assessed 18 h after ICSI seen in an immature oocyte, the oocyte was defined as germinal vesicle breakdown (GVBD). The mature oocytes were determined by for the appearance of two distinct pronuclei and two polar bodies. Following fertilization check, oocytes with two pronuclei (maxthe presence of a first polar body extrusion. All oocyte handling procedures were conducted on warm stages and plates at 37°C. COC imum five) were transferred into 1.0 ml of Medi-Cult IVF medium in the organ tissue culture dish (60ϫ15 mm; Falcon) for further were washed in TC-199 medium (Sigma Chemical Co., St Louis, MO, USA) with 10% inactivated (56°C, 30 min) fetal bovine serum culture. Embryos were transferred on day 2 or 3 after ICSI. Since the oocytes were not matured and inseminated at the same time (FBS; Sigma Chemical Co.). The immature oocytes were then incubated in an organ tissue culture dish (60ϫ15 mm; Falcon) following maturation in culture, the developmental stages of embryos and all patients had an endometrial thickness of 8 to 13 mm. Following embryo transfer, there were five clinical pregnancies (38.5%) among 13 treatment cycles in the HCG-primed group, and three clinical pregnancies (27.3%) among 11 treatment cycles in the non-HCG-primed group. The details of the pregnancies are shown in Table II . The time course of GVBD is shown in Figure 3 . At the time of oocyte retrieval in the HCG-primed group there were 46.2 Ϯ 5.2% GVBD oocytes; in contrast, in the non-HCGprimed group, no GVBD had occurred at the time of oocyte collection. After 48 h of culture, there was no significant difference in GVBD rates between the oocytes retrieved from the HCG-primed and non-primed groups (93.8 Ϯ 6.8% and 87.5 Ϯ 4.5% respectively). The time course of oocyte maturation was hastened in the HCG-primed group (Figure 4) , with The results of the present study indicate that the maturation For the preparation of the endometrium, the patients were given rate of immature oocytes retrieved from women with PCOS oestradiol (Estrace; Roberts Pharmaceutical, Mississauga, Canada) was improved by HCG priming. The first report of pregnancy depending on the endometrial thickness on the day of oocyte retrieval in a woman with anovulatory infertility following IVM of in divided doses, starting on the day of oocyte retrieval. If the immature oocytes and IVF was made in 1994 (Trounson et al., endometrial thickness on the day of oocyte retrieval was Ͻ4 mm, a 1994), while the following year, a pregnancy was reported in 10 mg dose was administered; if it was Ͼ6 mm, a 6 mg dose was a group of patients with PCOS treated with IVM, combined
given. More precise measurements of endometrial thickness were not with ICSI and assisted hatching (Barnes et al., 1995) . Unfortupossible with the equipment available at this stage of the treatment.
nately, only about 60% of immature oocytes retrieved from Luteal support was provided by 400 mg intravaginal progesterone women with PCOS mature in vitro, and the pregnancy rates (Prometrium) twice daily for 16 days starting from the day of ICSI.
reported have been correspondingly low, at approximately 22% On the day of embryo transfer, the endometrial thickness was measured again by transvaginal ultrasound scan. If the endometrial (Cha and Chian, 1998) . It has been reported that although thickness was Ͻ7 mm, the couples were offered embryo cryopreservimmature oocytes recovered from untreated ovaries can be ation and transfer in a subsequent cycle. Clinical pregnancy was matured, fertilized and developed in vitro, the implantation defined as an intrauterine gestation with a fetal heartbeat seen by rate of these cleaved embryos is disappointingly low, indicating transvaginal ultrasound scan. that the oocyte culture system may have specific requirements
The statistical significance of the differences between the means for successful human oocyte maturation (Barnes et al., 1996;  and percentages of the groups was determined and compared by Trounson et al., 1998) . The results of the current study Student-Newman-Keuls' test (Steel and Torrie, 1980) . A P-value demonstrate that the rate of oocyte maturation is significantly Ͻ 0.05 was considered statistically significant.
higher with HCG priming before immature oocyte retrieval, which may potentially increase the pregnancy rate, although Results this study was too small to detect any possible significant difference. As shown in Table I , there was no difference in the number of immature oocytes retrieved between the HCG-primed (13
The cyclic pattern of FSH and LH secretion in women with PCOS is typically absent, and there is often a disproportionately cycles) and the non-primed groups (11 cycles) (7.8 Ϯ 3.9 versus 7.4 Ϯ 5.2). However, the maturation rate of oocytes at high secretion of LH with a relatively constant low rate of FSH secretion (Yen, 1980) . The exact mechanism by which 48 h of culture was significantly different following culture, with HCG priming increasing the maturation rate of immature anovulation occurs in these women is unknown. There is a consensus that the common feature in women with PCOS is oocytes (84.3% versus 69.1%; P Ͻ0.05). The fertilization and cleavage rates and the embryo quality were comparable arrested follicular development at the stage when selection of the dominant follicle should normally occur (Erickson and between the HCG-primed group and the non-primed group. There were no cycles cancelled because of thin endometrium, Yen, 1984) . The initial steps of folliculogenesis, follicle recruit- adenylate cyclase results in elevated concentrations of cyclic adenosine monophosphate (cAMP) which then interacts with the regulatory subunits of protein kinase, resulting in production or activation of the appropriate enzymes (Marsh, 1976) . The action of oocyte maturation inhibitor (OMI) is itself inhibited by increased cAMP concentrations associated with the midcycle LH peak (Tsafriri and Pomerantz, 1986) . Excessive LH secretion is frequently encountered in women with PCOS (Waldstreicher et al., 1988) , and it has been shown that ity and miscarriage (Regan et al., 1990; Balen et al., 1993;  46.2 Ϯ 5.2% of oocytes showed GVBD. At 48 h culture, the Shoham et al., 1993) . is known that GVBD is initiated by the pre-ovulatory surge of LH, suggesting that LH induces the loss of communication ment, and follicle growth to the small antral stage, are functional in women with PCOS, but the terminal step-the selection of between the oocyte-cumulus cell complex, thus terminating the flow of OMI (Fagbohun and Downs, 1991) . The results of a dominant follicle that is capable of ovulation-does not occur regularly (Jakimiuk et al., 1997) . Normally, the mechanism of this study show that there were 46.2 Ϯ 5.2% of GVBD oocytes at the time of oocyte retrieval 36 h after HCG administration, LH action on the ovary starts with the binding to specific LH receptors on the theca and granulosa cells, followed by a which may suggest that the small follicles in polycystic ovaries possess some LH receptors, even though there is no direct rapid stimulation of adenylate cyclase activity. Stimulation of
